A patient has recovered from hepatitis B. Which discharge ...

[codyclark]

A patient has recovered from hepatitis B. Which discharge information should the nurse provide?
 
  1. You are now immune to getting hepatitis B again.
  2. Chronic hepatitis B may take years to develop.
  3. You should get hepatitis B vaccines annually.
  4. You should get hepatitis immunoglobulin annually.
  5. You should get one dose of interferon to boost your immunity to hepatitis B.

Question 2

The nurse is providing care to a client who is taking several different medications, both prescribed and over-the-counter (OTC). The nurse is consulting with the charge nurse about possible interactions. Which statement by the nurse explains the increased potential for adverse drugdrug and drugherbal interactions?
 
  1. The restrictions placed by the FDA are stricter.
  2. People are using more herbs, so the risk for interaction is greater.
  3. Drugs are being developed at a faster rate than their risk can be assessed.
  4. Managed care has made a greater number of drugs available to consumers.

[frejo]

Answer to Question 1

1,2
Rationale 1: The patient is immune to a new case of hepatitis B.
Rationale 2: Symptoms of chronic HBV may develop as long as 10 years following exposure.
Rationale 3: There is no need to get a hepatitis B vaccine.
Rationale 4: There is no need to get hepatitis immunoglobulins.
Rationale 5: There is no need to get a dose of interferon.

Global Rationale: The patient is immune to a new case of hepatitis B. Symptoms of chronic HBV may develop as long as 10 years following exposure. There is no need to get a hepatitis B vaccine, hepatitis immunoglobulin, or interferon.

Answer to Question 2

3

Rationale 1:The restrictions placed by the FDA are stricter is incorrect because FDA restrictions are broader, and cover information about nonFDA-approved uses of certain drugs.
Rationale 2:People are using more herbs, so the risk for interaction is greater is incorrect. While the use of herbal products has increased, this is not the underlying reason for increased adverse potential.
Rationale 3:Drugs are being developed at a faster rate than their risk can be assessed is correct. Because of the higher number of drugs being approved for therapy, the potential for adverse drugdrug and drugherbal interactions is greater than ever before.
Rationale 4:Managed care has made a greater number of drugs available to consumers is incorrect because managed care involvement does not come into play with higher number of interactions.

Global Rationale: Drugs are being developed at a faster rate than their risk can be assessed is correct. Because of the higher number of drugs being approved for therapy, the potential for adverse drugdrug and drugherbal interactions is greater than ever before. The restrictions placed by the FDA are stricter is incorrect because FDA restrictions are broader, and cover information about nonFDA-approved uses of certain drugs. People are using more herbs, so the risk for interaction is greater is incorrect. While the use of herbal products has increased, this is not the underlying reason for increased adverse potential. Managed care has made a greater number of drugs available to consumers is incorrect because managed care involvement does not come into play with higher number of interactions.

[codyclark]

Excellent

[AmberC1996]

TYSM